| RS121434594 |
RAF1
|
Health Risk |
Pathogenic/Likely pathogenic |
Noonan syndrome 5, Primary familial hypertrophic cardiomyopathy |
| RS121434595 |
NRAS
|
Health Risk |
Likely pathogenic |
Carcinoma of colon, Large congenital melanocytic nevus |
| RS121434596 |
NRAS
|
Health Risk |
Likely pathogenic |
Juvenile myelomonocytic leukemia, Noonan syndrome 6 |
| RS121434597 |
PTH1R
|
Health Risk |
Pathogenic |
Metaphyseal chondrodysplasia, Jansen type |
| RS121434598 |
PTH1R
|
Health Risk |
Pathogenic |
Metaphyseal chondrodysplasia, Jansen type |
| RS121434599 |
PTH1R
|
Health Risk |
Pathogenic |
Chondrodysplasia Blomstrand type, Metaphyseal chondrodysplasia |
| RS121434600 |
PTH1R
|
Health Risk |
Pathogenic |
Metaphyseal chondrodysplasia, Jansen type |
| RS121434602 |
PTH1R
|
Health Risk |
Pathogenic |
Metaphyseal chondrodysplasia, Jansen type |
| RS121434603 |
PTH1R
|
Health Risk |
Pathogenic |
Eiken syndrome, Eiken syndrome |
| RS121434604 |
PTH1R
|
Health Risk |
Pathogenic |
Chondrodysplasia Blomstrand type, Chondrodysplasia Blomstrand type |
| RS121434605 |
PTH1R
|
Health Risk |
Pathogenic |
Primary failure of tooth eruption, Primary failure of tooth eruption |
| RS121434608 |
GDI1
|
Health Risk |
Pathogenic |
Intellectual disability, X-linked 41 |
| RS121434609 |
GDI1
|
Health Risk |
Pathogenic |
Intellectual disability, X-linked 41 |
| RS121434610 |
SMS
|
Health Risk |
Pathogenic |
Syndromic X-linked intellectual disability Snyder type, Inborn genetic diseases |
| RS121434611 |
PAK3
|
Health Risk |
Pathogenic |
Intellectual disability, X-linked 30 |
| RS121434612 |
PAK3
|
Health Risk |
Pathogenic |
Intellectual disability, X-linked 30 |
| RS121434613 |
PAK3
|
Health Risk |
Pathogenic |
Intellectual disability, X-linked 30 |
| RS121434614 |
PAK3
|
Health Risk |
Pathogenic |
Intellectual disability, X-linked 30 |
| RS121434615 |
CUL4B
|
Health Risk |
Pathogenic |
X-linked intellectual disability Cabezas type, X-linked intellectual disability Cabezas type |
| RS121434616 |
CUL4B
|
Health Risk |
Pathogenic |
X-linked intellectual disability Cabezas type, Global developmental delay |
| RS121434618 |
BCOR
|
Health Risk |
Pathogenic |
Oculofaciocardiodental syndrome, Oculofaciocardiodental syndrome |
| RS121434619 |
BCOR
|
Health Risk |
Pathogenic |
Oculofaciocardiodental syndrome, Oculofaciocardiodental syndrome |
| RS121434621 |
OPN1LW
|
Health Risk |
Pathogenic |
Cone monochromatism, Protan defect |
| RS121434622 |
FMR1
|
Health Risk |
Pathogenic |
Fragile X syndrome, Fragile X syndrome |
| RS121434623 |
PTPN12
|
Health Risk |
Pathogenic |
Carcinoma of colon, Carcinoma of colon |
| RS121434624 |
CREBBP
|
Health Risk |
Pathogenic |
Rubinstein-Taybi syndrome due to CREBBP mutations, Rubinstein-Taybi syndrome due to CREBBP mutations |
| RS121434625 |
CREBBP
|
Health Risk |
Pathogenic |
Rubinstein-Taybi syndrome due to CREBBP mutations, Rubinstein-Taybi syndrome due to CREBBP mutations |
| RS121434626 |
CREBBP
|
Health Risk |
Pathogenic |
Rubinstein-Taybi syndrome due to CREBBP mutations, CREBBP-related disorder |
| RS121434629 |
PMS2
|
Health Risk |
Pathogenic/Likely pathogenic |
Mismatch repair cancer syndrome 1, Lynch syndrome 4 |
| RS121434630 |
PMS2
|
Health Risk |
Pathogenic |
Mismatch repair cancer syndrome 4, Mismatch repair cancer syndrome 4 |
| RS121434631 |
GUCA1A;GUCA1ANB-GUCA1A
|
Health Risk |
Pathogenic |
Retinal dystrophy, Cone-rod dystrophy 14 |
| RS121434632 |
BBS4
|
Health Risk |
Pathogenic |
Bardet-Biedl syndrome 4, Bardet-Biedl syndrome |
| RS121434633 |
NTRK2
|
Health Risk |
Pathogenic |
Obesity, hyperphagia |
| RS121434634 |
PLA2G4A
|
Health Risk |
Pathogenic |
Cytosolic phospholipase-A2 alpha deficiency associated bleeding disorder, Cytosolic phospholipase-A2 alpha deficiency associated bleeding disorder |
| RS121434635 |
PLA2G4A
|
Health Risk |
Pathogenic |
Cytosolic phospholipase-A2 alpha deficiency associated bleeding disorder, Cytosolic phospholipase-A2 alpha deficiency associated bleeding disorder |
| RS121434636 |
AUH
|
Health Risk |
Pathogenic |
3-methylglutaconic aciduria type 1, 3-methylglutaconic aciduria type 1 |
| RS121434637 |
ETV6
|
Health Risk |
Pathogenic |
Acute myeloid leukemia, Acute myeloid leukemia |
| RS121434638 |
TNNT3
|
Health Risk |
Pathogenic/Likely pathogenic |
Arthrogryposis, distal |
| RS121434639 |
DDB2
|
Health Risk |
Pathogenic |
Xeroderma pigmentosum, group E |
| RS121434640 |
DDB2
|
Health Risk |
Pathogenic/Likely pathogenic |
Xeroderma pigmentosum, group E |
| RS121434641 |
DDB2
|
Health Risk |
Pathogenic |
Xeroderma pigmentosum, group E |
| RS121434642 |
DDB2
|
Health Risk |
Pathogenic |
Xeroderma pigmentosum, group E |
| RS121434643 |
GJA8
|
Health Risk |
Pathogenic/Likely pathogenic |
Cataract 1 multiple types, Cataract 1 multiple types |
| RS1214399996 |
SACS
|
Health Risk |
Pathogenic |
Charlevoix-Saguenay spastic ataxia, Spastic paraplegia |
| RS1214424848 |
FLG
|
Health Risk |
Pathogenic |
Dermatitis, atopic |
| RS1214440741 |
DGKE
|
Health Risk |
Pathogenic |
Immunoglobulin-mediated membranoproliferative glomerulonephritis, Immunoglobulin-mediated membranoproliferative glomerulonephritis |
| RS1214448436 |
ITGA2B
|
Health Risk |
Pathogenic |
Glanzmann thrombasthenia, Glanzmann thrombasthenia |
| RS1214449764 |
LZTR1
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Hereditary cancer-predisposing syndrome |
| RS1214453791 |
ANK2
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Long QT syndrome |
| RS1214465435 |
PROP1
|
Health Risk |
Pathogenic |
Pituitary hormone deficiency, combined |
| RS1214483973 |
ZFYVE26
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 15, Spastic paraplegia |
| RS1214485253 |
CBL
|
Health Risk |
Conflicting classifications of pathogenicity |
RASopathy, Cardiovascular phenotype |
| RS1214495121 |
IDUA
|
Health Risk |
Likely pathogenic |
Hurler syndrome, Mucopolysaccharidosis type 1 |
| RS1214505775 |
MYO5B
|
Health Risk |
Pathogenic |
— |
| RS1214541502 |
ATM
|
Health Risk |
Pathogenic/Likely pathogenic |
Ataxia-telangiectasia syndrome, Hereditary cancer-predisposing syndrome |
| RS1214542902 |
ACADSB
|
Health Risk |
Pathogenic |
Deficiency of 2-methylbutyryl-CoA dehydrogenase, Deficiency of 2-methylbutyryl-CoA dehydrogenase |
| RS1214597671 |
PMS2
|
Health Risk |
Pathogenic |
Hereditary nonpolyposis colorectal neoplasms, Lynch syndrome 4 |
| RS1214621343 |
NR0B1
|
Health Risk |
Pathogenic |
Congenital adrenal hypoplasia, X-linked |
| RS1214623286 |
AGRN
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital myasthenic syndrome 8, Inborn genetic diseases |
| RS1214626558 |
IL10RA
|
Health Risk |
Pathogenic |
Inflammatory bowel disease 28, Inflammatory bowel disease 28 |
| RS1214630241 |
GPHN
|
Health Risk |
Pathogenic |
Sulfite oxidase deficiency due to molybdenum cofactor deficiency type C, Sulfite oxidase deficiency due to molybdenum cofactor deficiency type C |
| RS1214642702 |
COG5
|
Health Risk |
Pathogenic |
COG5-congenital disorder of glycosylation, COG5-congenital disorder of glycosylation |
| RS1214646363 |
TP53
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Li-Fraumeni syndrome |
| RS1214646426 |
WT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Drash syndrome, Frasier syndrome |
| RS1214659869 |
LZTR1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Cardiovascular phenotype |
| RS1214660308 |
DSP
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiomyopathy, Arrhythmogenic cardiomyopathy with wooly hair and keratoderma |
| RS1214672768 |
ADGRV1
|
Health Risk |
Pathogenic |
Usher syndrome type 2C, Usher syndrome type 2C |
| RS12146878 |
MYBPC1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1214719967 |
RAI1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1214723183 |
DIS3L2
|
Health Risk |
Likely pathogenic |
Perlman syndrome, Perlman syndrome |
| RS1214757167 |
ALS2
|
Health Risk |
Conflicting classifications of pathogenicity |
Amyotrophic lateral sclerosis type 2, juvenile |
| RS1214763097 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary breast ovarian cancer syndrome, Hereditary cancer-predisposing syndrome |
| RS1214763792 |
BCKDHA
|
Health Risk |
Pathogenic/Likely pathogenic |
Maple syrup urine disease, Maple syrup urine disease |
| RS1214781989 |
GNS
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis, MPS-III-D |
| RS1214801816 |
DYNC2H1
|
Health Risk |
Pathogenic/Likely pathogenic |
Asphyxiating thoracic dystrophy 3, Asphyxiating thoracic dystrophy 3 |
| RS1214812785 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1214818871 |
LARS2
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS1214822130 |
MTMR2
|
Health Risk |
Likely pathogenic |
Charcot-Marie-Tooth disease type 4B1, Charcot-Marie-Tooth disease type 4B1 |
| RS1214837315 |
GRIN2B
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 27 |
| RS1214848359 |
EVC2
|
Health Risk |
Likely pathogenic |
Ellis-van Creveld syndrome, Curry-Hall syndrome |
| RS1214866139 |
GALK1
|
Health Risk |
Conflicting classifications of pathogenicity |
Deficiency of galactokinase, Deficiency of galactokinase |
| RS1214876593 |
TCIRG1
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive osteopetrosis 1, Autosomal recessive osteopetrosis 1 |
| RS1214897554 |
MKS1
|
Health Risk |
Likely pathogenic |
Bardet-Biedl syndrome 13, Bardet-Biedl syndrome 13 |
| RS1214903860 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary breast ovarian cancer syndrome |
| RS1214951193 |
MYO7A
|
Health Risk |
Pathogenic |
— |
| RS1214956593 |
NAGS
|
Health Risk |
Pathogenic |
Hyperammonemia, type III |
| RS1214965807 |
PTEN
|
Health Risk |
Pathogenic |
PTEN hamartoma tumor syndrome, Hereditary cancer-predisposing syndrome |
| RS1214970789 |
ARID1B
|
Health Risk |
Conflicting classifications of pathogenicity |
Coffin-Siris syndrome 1, Inborn genetic diseases |
| RS1214971073 |
PEX12
|
Health Risk |
Likely pathogenic |
Peroxisome biogenesis disorder type 3B, Peroxisome biogenesis disorder 3A (Zellweger) |
| RS1214977180 |
CNTNAP4
|
Health Risk |
Conflicting classifications of pathogenicity |
CNTNAP4-related disorder, CNTNAP4-related disorder |
| RS1214978129 |
TYMP
|
Health Risk |
Pathogenic |
— |
| RS1214978641 |
ZBTB24
|
Health Risk |
Likely pathogenic |
— |
| RS1214983921 |
CYP11B1
|
Health Risk |
Pathogenic |
Deficiency of steroid 11-beta-monooxygenase, Glucocorticoid-remediable aldosteronism |
| RS1214987088 |
P3H1
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type 8, Osteogenesis imperfecta type 8 |
| RS1214999277 |
PKP2
|
Health Risk |
Pathogenic |
Arrhythmogenic right ventricular dysplasia 9, Arrhythmogenic right ventricular dysplasia 9 |
| RS1215010372 |
AGXT
|
Health Risk |
Likely pathogenic |
Primary hyperoxaluria, type I |
| RS1215015585 |
ALMS1
|
Health Risk |
Pathogenic |
Alstrom syndrome, Alstrom syndrome |
| RS1215020674 |
CPT2
|
Health Risk |
Pathogenic |
Carnitine palmitoyltransferase II deficiency, Carnitine palmitoyltransferase II deficiency |
| RS1215026981 |
LDLRAP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypercholesterolemia, familial |
| RS1215030552 |
DYNC2H1
|
Health Risk |
Likely pathogenic |
Asphyxiating thoracic dystrophy 3, Asphyxiating thoracic dystrophy 3 |